business
Popular antidepressant recalled over high levels of a cancer-causing compound
Summary by The Trophy Club Editorial Desk Danielle Abreu , as published by NBC 5 Dallas-Fort Worth (KXAS)
· June 19, 2026
· 1 min read
Story provenance No corrections
Summary created by The Trophy Club Editorial Desk — automated, rule-governed Byline on source page Danielle Abreu, as published by NBC 5 Dallas-Fort Worth (KXAS) Original story Read at the source Source published Jun 19, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key points Further details about the recall are available from NBC 5 Dallas-Fort Worth, including information on the affected products and what users should do next. The recall was initiated by Breckenridge Pharmaceuticals, a New Jersey-based drug company, due to high levels of a cancer-causing compound found in bottles of the prescription drug.
A recall has been issued for a popular antidepressant due to potential health risks. The medication in question is duloxetine, a generic version of Cymbalta, which is used to treat various conditions.
The recall was initiated by Breckenridge Pharmaceuticals, a New Jersey-based drug company, due to high levels of a cancer-causing compound found in bottles of the prescription drug.
Further details about the recall are available from NBC 5 Dallas-Fort Worth, including information on the affected products and what users should do next.
More business Today’s briefing Local events
Why this matters
Local business news drives decisions about where to shop, where to invest, and where to apply for jobs. The Trophy Club covers openings, closings, expansions, and economic shifts because each one ripples through the community.
About this story
As published by NBC 5 Dallas-Fort Worth (KXAS) . The Trophy Club surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit NBC 5 Dallas-Fort Worth (KXAS) . Have a tip or correction? Contact our newsroom .
Category: business Published: June 19, 2026 Source: NBC 5 Dallas-Fort Worth (KXAS) Reading time: 1 min
Frequently asked about this story
What is this story about? A recall has been issued for a popular antidepressant due to potential health risks. The medication in question is duloxetine, a generic version of Cymbalta, which is used to treat various…
When was this published? This article was first published on June 19, 2026 by NBC 5 Dallas-Fort Worth (KXAS) and curated for The Trophy Club readers.
Who reported this story? This story was reported by Danielle Abreu at NBC 5 Dallas-Fort Worth (KXAS). To learn more about how The Trophy Club selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more business coverage from The Trophy Club, or browse our daily briefing and topic hubs .
← Back to all news
More business →
Today’s briefing
Subscribe to newsletter
